Institutional members access full text with Ovid®

Share this article on:

Patient Recall of Informed Consent at 4 Weeks After Total Hip Replacement With Standardized Versus Procedure-Specific Consent Forms

Pomeroy, Eoghan; Shaarani, Shahril; Kenyon, Robert; Cashman, James

doi: 10.1097/PTS.0000000000000412
Original Article: PDF Only

Objectives Informed consent plays a pivotal role in the operative process, and surgeons have an ethical and legal obligation to provide patients with information to allow for shared decision-making. Unfortunately, patient recall after the consent process is frequently poor. This study aims to evaluate the effect of procedure-specific consent forms on patient's recall four weeks after total hip replacement (THR).

Methods This is a prospective study using a posttest-only control group design. Sixty adult patients undergoing total hip replacement were allocated to be consented using either the generic or the surgery-specific consent form. Four weeks after surgery, a phone interview was conducted to assess patient's recall of risk of surgical complications.

Results Patient demographic characteristics and educational attainment were similar in both groups. There was a statistically significant increase in the mean number of risks recalled in the study group at 1.43 compared with 0.67 in the control group (P = 0.0131).

Conclusions Consent is a complex process, and obtaining informed consent is far from straightforward. A statistically significant improvement in patient's recall with the use of procedure-specific consent forms was identified, and based on this, we would advocate their use. However, overall patient recall in both groups was poor. We believe that improving the quality of informed consent may require the sum of small gains, and the use of procedure-specific consent forms may aid in this regard.

From Cappagh National Orthopaedic Hospital, Dublin, Ireland.

Correspondence: Eoghan Pomeroy, MB, BCh, BAO, Cappagh National Orthopaedic Hospital, Dublin, Ireland (e-mail:

The authors disclose no conflict of interest.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved